A mutation in β-amyloid precursor protein renders SH‑SY5Y cells vulnerable to isoflurane toxicity: The role of inositol 1,4,5‑trisphosphate receptors

β-淀粉样蛋白前体突变导致 SH‑SY5Y 细胞易受异氟烷毒性影响:肌醇 1,4,5‑三磷酸受体的作用

阅读:7
作者:Xiang Liu, Shan Song, Qiujun Wang, Tianbao Yuan, Jihua He

Abstract

Isoflurane is a commonly used inhaled anesthetic, which induces apoptosis of SH‑SY5Y cells in a dose‑ and time‑dependent manner; however, the underlying mechanisms remain unknown. The authors of the present study hypothesized that a mutation in β‑amyloid precursor protein (APP), which is a gene associated with familial Alzheimer's disease, may render cells vulnerable to isoflurane‑induced cytotoxicity via activation of inositol 1,4,5‑trisphosphate receptors (IP3R). In the present study, SH‑SY5Y cells were transfected with a vector or with mutated APP, and were treated with the equivalent of 1 minimum alveolar concentration (MAC) isoflurane for 8 h. Cell apoptosis rate, alterations to cytosolic calcium concentrations ([Ca2+]c), and protein levels of IP3R were determined following exposure of cells to isoflurane. In addition, the effects of the IP3R antagonist xestospongin C were determined on isoflurane‑induced cytotoxicity and calcium release from the endoplasmic reticulum (ER) of mutated APP‑ and vector‑transfected SH‑SY5Y cells. Treatment with isoflurane (1 MAC) for 8 h induced a higher degree of cytotoxicity, and a marked increase in [Ca2+]c and IP3R protein levels in mutated APP‑transfected SH‑SY5Y cells compared with vector‑transfected SH‑SY5Y cells. Xestospongin C significantly attenuated isoflurane‑mediated cytotoxicity and inhibited calcium release from the ER of SH‑SY5Y cells. These results indicated that the APP mutation may render SH‑SY5Y cells vulnerable to isoflurane neurotoxicity, and the underlying mechanism may be associated with Ca2+ dysregulation via overactivation of IP3R.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。